Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Molecular Quality Controls Market, by Analyte Type
1.4.2 North America Molecular Quality Controls Market, by Application
1.4.3 North America Molecular Quality Controls Market, by Product
1.4.4 North America Molecular Quality Controls Market, by End User
1.4.5 North America Molecular Quality Controls Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies deployed in Molecular Quality Controls Market
Chapter 4. North America Molecular Quality Controls Market by Analyte Type
4.1 North America Single-analyte Controls Market by Country
4.2 North America Multi-analyte Controls Market by Country
Chapter 5. North America Molecular Quality Controls Market by Application
5.1 North America Infectious Diseases Diagnostics Market by Country
5.2 North America Oncology Testing Market by Country
5.3 North America Genetic Testing Market by Country
5.4 North America Other Application Market by Country
Chapter 6. North America Molecular Quality Controls Market by Product
6.1 North America Independent Controls Market by Country
6.2 North America Instrument-specific Controls Market by Country
6.3 North America Molecular Quality Controls Market by Instrument-specific Controls Type
6.3.1 North America PCR Market by Country
6.3.2 North America DNA Sequencing & NGS Market by Country
6.3.3 North America Others Market by Country
Chapter 7. North America Molecular Quality Controls Market by End User
7.1 North America Diagnostic Laboratories Market by Country
7.2 North America Hospitals Market by Country
7.3 North America IVD Manufacturers & CROs Market by Country
7.4 North America Academic & Research Institutes Market by Country
7.5 North America Others Market by Country
Chapter 8. North America Molecular Quality Controls Market by Country
8.1 US Molecular Quality Controls Market
8.1.1 US Molecular Quality Controls Market by Analyte Type
8.1.2 US Molecular Quality Controls Market by Application
8.1.3 US Molecular Quality Controls Market by Product
8.1.3.1 US Molecular Quality Controls Market by Instrument-specific Controls Type
8.1.4 US Molecular Quality Controls Market by End User
8.2 Canada Molecular Quality Controls Market
8.2.1 Canada Molecular Quality Controls Market by Analyte Type
8.2.2 Canada Molecular Quality Controls Market by Application
8.2.3 Canada Molecular Quality Controls Market by Product
8.2.3.1 Canada Molecular Quality Controls Market by Instrument-specific Controls Type
8.2.4 Canada Molecular Quality Controls Market by End User
8.3 Mexico Molecular Quality Controls Market
8.3.1 Mexico Molecular Quality Controls Market by Analyte Type
8.3.2 Mexico Molecular Quality Controls Market by Application
8.3.3 Mexico Molecular Quality Controls Market by Product
8.3.3.1 Mexico Molecular Quality Controls Market by Instrument-specific Controls Type
8.3.4 Mexico Molecular Quality Controls Market by End User
8.4 Rest of North America Molecular Quality Controls Market
8.4.1 Rest of North America Molecular Quality Controls Market by Analyte Type
8.4.2 Rest of North America Molecular Quality Controls Market by Application
8.4.3 Rest of North America Molecular Quality Controls Market by Product
8.4.3.1 Rest of North America Molecular Quality Controls Market by Instrument-specific Controls Type
8.4.4 Rest of North America Molecular Quality Controls Market by End User
Chapter 9. Company Profiles
9.1 Grifols, S.A
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Regional & Segmental Analysis
9.1.4 Research & Development Expenses
9.1.5 Recent strategies and developments:
9.1.5.1 Approvals:
9.2 Abbott Laboratories
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.3 Quidel Corporation
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Regional Analysis
9.3.4 Research & Development Expense
9.4 Thermo Fisher Scientific, Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 Recent strategies and developments:
9.4.5.1 Product Launches and Product Expansions:
9.4.6 SWOT Analysis
9.5 Bio-Rad laboratories, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expenses
9.5.5 Recent strategies and developments:
9.5.5.1 Partnerships, Collaborations, and Agreements:
9.6 Seegene, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Research & Development Expense
9.7 Randox Laboratories Limited
9.7.1 Company Overview
9.8 F. Hoffmann-La Roche Ltd.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expense
9.8.5 Recent strategies and developments:
9.8.5.1 Product Launches and Product Expansions:
9.9 Bio-Techne Corporation
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expense
9.10. Microbiologics, Inc.
9.10.1 Company Overview
9.10.2 Recent strategies and developments:
9.10.2.1 Product Launches and Product Expansions:
Unique Offerings 
